Cystatin C in kidney dysfunction and identification of risk factors in people aged 30 to 34 years

Abstract

Cystatin C has emerged as a sensitive and specific biomarker for assessing kidney function, allowing for earlier detection of kidney dysfunction compared to other traditional markers. This study aimed to assess the usefulness of cystatin C in kidney dysfunction and identify risk factors in residents of Jipijapa. An observational, descriptive, and cross-sectional methodology was used, with a sample of 50 adults aged 30–34 years, treated at the Jipijapa Basic Hospital. Of the total, 74% were women and 26% were men. The results revealed that 98% of participants had normal cystatin C levels (0.56–0.90 mg/dL), while only 2% had elevated levels (up to 1.09 mg/dL). Regarding risk factors, overweight and obesity were the most common, affecting 44%, especially women. Hypertension was identified in 6% of cases, and diabetes in 10%. In conclusion, cystatin C represents a valuable diagnostic tool for the prevention of kidney disease, allowing early identification of at-risk patients and contributing to timely intervention.